吉住 朋晴

Medicine and Dentistry

1. Donor 100%
2. Patient 94%
3. Liver Transplantation 91%
4. Hepatocellular Carcinoma 50%
5. Hepatectomy 33%
6. Liver 28%
7. Surgery 24%
8. Neoplasm 19%
9. Inpatient 19%
10. Recurrent Disease 18%
11. Therapeutic Procedure 15%
12. Adult 13%
13. Computer Assisted Tomography 11%
14. Overall Survival 10%
15. Cholangiocarcinoma 10%
16. Survival Rate 9%
17. Recurrence Free Survival 9%
18. Hepatic Vein 8%
19. Serum 8%
20. Prognosis 7%
21. Hepatic Portal Vein 7%
22. Liver Graft 7%
23. Incidence 7%
24. Predictor 7%
25. Hospital 6%
26. Combination Therapy 6%
27. Tissues 6%
28. Transplantation 6%
29. Splenectomy 6%
30. Analysis 6%
31. Common Hepatic Artery 6%
32. Hepatitis C 6%
33. Age 6%
34. Bleeding 5%
35. Malignant Neoplasm 5%
36. Survival 5%
37. Portal Vein Thrombosis 5%
38. Surgical Anastomosis 5%
39. Liver Cirrhosis 5%
40. Multivariate Analysis 5%
41. Lymphocyte 5%
42. Syndrome 5%
43. Graft Survival 5%